156 related articles for article (PubMed ID: 34478833)
41. Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies.
Fokdal L; Tanderup K; Pötter R; Sturdza A; Kirchheiner K; Chargari C; Jürgenliemk-Schulz IM; Segedin B; Tan LT; Hoskin P; Mahantshetty U; Bruheim K; Rai B; Kirisits C; Lindegaard JC;
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):887-894. PubMed ID: 30419309
[TBL] [Abstract][Full Text] [Related]
42. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.
Mazeron R; Fokdal LU; Kirchheiner K; Georg P; Jastaniyah N; Šegedin B; Mahantshetty U; Hoskin P; Jürgenliemk-Schulz I; Kirisits C; Lindegaard JC; Dörr W; Haie-Meder C; Tanderup K; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):412-419. PubMed ID: 27396811
[TBL] [Abstract][Full Text] [Related]
43. Quality of life and sexual function of patients following radical hysterectomy and vaginal extension.
Ye S; Yang J; Cao D; Zhu L; Lang J; Chuang LT; Shen K
J Sex Med; 2014 May; 11(5):1334-42. PubMed ID: 24628816
[TBL] [Abstract][Full Text] [Related]
44. Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study.
Waetjen LE; Crawford SL; Chang PY; Reed BD; Hess R; Avis NE; Harlow SD; Greendale GA; Dugan SA; Gold EB;
Menopause; 2018 Oct; 25(10):1094-1104. PubMed ID: 29916947
[TBL] [Abstract][Full Text] [Related]
45. IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study.
Lőcsei Z; Sebestyén K; Sebestyén Z; Fehér E; Soltész D; Musch Z; Mangel LC
Pathol Oncol Res; 2021; 27():608446. PubMed ID: 34257570
[No Abstract] [Full Text] [Related]
46. Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule.
Facondo G; Vullo G; Sanctis V; Vitiello C; Nieddu L; Alfò M; Scaringi C; Felice F; Rotondi M; Giacomo F; Ruscito I; Valeriani M; Osti MF
J Contemp Brachytherapy; 2022 Aug; 14(4):341-346. PubMed ID: 36199948
[TBL] [Abstract][Full Text] [Related]
47. Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma.
Quick AM; Seamon LG; Abdel-Rasoul M; Salani R; Martin D
Int J Gynecol Cancer; 2012 May; 22(4):703-8. PubMed ID: 22398710
[TBL] [Abstract][Full Text] [Related]
48. Long-term effects of neoadjuvant chemoradiotherapy followed by sphincter-preserving resection on anal sphincter function in relation to quality of life among locally advanced rectal cancer patients: a cross-sectional analysis.
Ozgen Z; Ozden S; Atasoy BM; Ozyurt H; Gencosmanoglu R; Imeryuz N
Radiat Oncol; 2015 Aug; 10():168. PubMed ID: 26264590
[TBL] [Abstract][Full Text] [Related]
49. Feasibility of implementing a cervix cancer-specific patient-reported outcome measure in routine ambulatory clinics.
Atallah S; Barbera L; Folwell M; Howell D; Liu Z; Croke J
Support Care Cancer; 2021 Jan; 29(1):499-507. PubMed ID: 32405964
[TBL] [Abstract][Full Text] [Related]
50. Sexual Function, Quality of Life, and Mood After Radiation Therapy in Patients with Anal Cancer.
Yerramilli D; Drapek L; Nipp RD; Horick N; Moran SMC; Noé B; D'Arpino SM; Mitra D; Hong TS; Ryan DP; Dizon DS; Wo J
J Gastrointest Cancer; 2020 Mar; 51(1):204-210. PubMed ID: 30980294
[TBL] [Abstract][Full Text] [Related]
51. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer.
Juraskova I; Jarvis S; Mok K; Peate M; Meiser B; Cheah BC; Mireskandari S; Friedlander M
J Sex Med; 2013 Oct; 10(10):2549-58. PubMed ID: 23635341
[TBL] [Abstract][Full Text] [Related]
52. Sexual distress and associated factors among cervical cancer survivors: A cross-sectional multicenter observational study.
Bakker RM; Kenter GG; Creutzberg CL; Stiggelbout AM; Derks M; Mingelen W; Kroon CD; Vermeer WM; Ter Kuile MM
Psychooncology; 2017 Oct; 26(10):1470-1477. PubMed ID: 27862635
[TBL] [Abstract][Full Text] [Related]
53. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
54. Assessment of Quality of Life and Urinary and Sexual Function After Radical Hysterectomy in Long-Term Cervical Cancer Survivors.
Plotti F; Terranova C; Capriglione S; Crispino S; Li Pomi A; de Cicco Nardone C; Montera R; Panici PB; Angioli R; Scaletta G
Int J Gynecol Cancer; 2018 May; 28(4):818-823. PubMed ID: 29538249
[TBL] [Abstract][Full Text] [Related]
55. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
[TBL] [Abstract][Full Text] [Related]
56. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
[TBL] [Abstract][Full Text] [Related]
57. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
[TBL] [Abstract][Full Text] [Related]
58. Sexual function and quality of life in women with cervical cancer before radiotherapy: a pilot study.
Grion RC; Baccaro LF; Vaz AF; Costa-Paiva L; Conde DM; Pinto-Neto AM
Arch Gynecol Obstet; 2016 Apr; 293(4):879-86. PubMed ID: 26319157
[TBL] [Abstract][Full Text] [Related]
59. Quality of life and sexuality comparison between sexually active ovarian cancer survivors and healthy women.
Kim SI; Lee Y; Lim MC; Joo J; Park K; Lee DO; Park SY
J Gynecol Oncol; 2015 Apr; 26(2):148-54. PubMed ID: 25686396
[TBL] [Abstract][Full Text] [Related]
60. [Sexual function and quality of life in locally advanced cervical cancer].
Grangé C; Bonal M; Huyghe É; Lèguevaque P; Cances-Lauwers V; Motton S
Gynecol Obstet Fertil; 2013 Feb; 41(2):116-22. PubMed ID: 23380465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
